FLIT typically presents in newborns or young infants with respiratory distress. Symptoms may include difficulty breathing, rapid breathing, and cyanosis (a bluish tint to the skin due to lack of oxygen). In some cases, the tumor may be detected prenatally through ultrasound, showing as a mass in the fetal lung.

The diagnostic workup for FLIT involves imaging studies and possibly a biopsy. An ultrasound or MRI may be used prenatally to identify the tumor. After birth, a chest X-ray or CT scan can provide detailed images of the lung and help confirm the presence of a tumor. In some cases, a biopsy, which involves taking a small sample of tissue for examination under a microscope, may be necessary to rule out other types of lung masses.

Treatment for FLIT depends on the size and impact of the tumor. In some cases, the tumor may shrink on its own, requiring only monitoring. If the tumor causes significant respiratory distress or other complications, surgical removal may be necessary. The surgery involves removing the tumor while preserving as much healthy lung tissue as possible.

The prognosis for infants with FLIT is generally good, especially if the tumor is detected early and managed appropriately. Many infants recover fully after treatment, with normal lung function. However, the outcome can vary depending on the size of the tumor and the presence of any complications.

The exact cause of FLIT is not well understood. It is believed to result from abnormal development of lung tissue during fetal growth. There is no known genetic or environmental factor that has been definitively linked to the development of FLIT.

FLIT is extremely rare, with only a few cases reported in medical literature. Due to its rarity, there is limited data on its prevalence and incidence. It appears to affect both genders equally and does not show a preference for any particular ethnic group.

FLIT involves the proliferation of mesenchymal cells, which are a type of cell that contributes to the formation of connective tissues. These cells grow abnormally within the lung's interstitial tissue, leading to the formation of a mass. This mass can interfere with normal lung function, causing respiratory symptoms.

There are no known preventive measures for FLIT, as its exact cause is not understood. Prenatal care and regular monitoring during pregnancy can help in early detection, allowing for timely intervention if necessary.

Fetal Lung Interstitial Tumor is a rare, non-cancerous lung tumor that affects newborns and infants. It presents with respiratory distress and is diagnosed through imaging studies. Treatment may involve monitoring or surgical removal, with a generally good prognosis. The cause of FLIT is unknown, and it is extremely rare, with no known preventive measures.

For parents of infants diagnosed with FLIT, it is important to understand that this condition, while serious, is not cancerous. With appropriate medical care, most infants recover well. Regular follow-up with healthcare providers is crucial to monitor the infant's lung function and overall health. If surgery is required, it is typically successful in resolving the symptoms and allowing the child to grow and develop normally.